Nachrichten zur Ocular Therapeutix Aktie

Ocular Therapeutix™ to Present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

BEDFORD, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation,…

Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 6.90% and 3.75%, respectively, for the quarter ended June 2023. Do…

Form 8-K OCULAR THERAPEUTIX, INC For: Jul 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Medical Officer verkauft Aktien von Ocular Therapeutix im Wert von 4.102$

Ozden, Rabia Gurses - Vorstand - Tag der Transaktion: 2023-07-07...…

Cytophage Technologies Inc. Board of Directors Welcomes New Member and Board Advisor

COMMERCIALIZATION EXPERT JOINS THE CYTOPHAGE TEAM Winnipeg, Manitoba - TheNewswire - July 6, 2023 - Cytophage Technologies Inc., a Canadian biotech…

Form 8-K OCULAR THERAPEUTIX, INC For: Jun 14

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ocular Therapeutix™ To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting

BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the…

Ocular Therapeutix™ to Present at the Jefferies Global Healthcare Conference

BEDFORD, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation,…

Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -14.81% and 4.62%, respectively, for the quarter ended March 2023. Do…

Nach Kursexplosion bei Ocular Therapeutix, InflaRx, Immatics – das sind die nächsten Biotech-Gamechanger

Es geht weiter Schlag auf Schlag. Im April löste das grüne Licht für ein Covid-Medikament des thüringischen Biotech-Unternehmens InflaRx eine…

Ocular Therapeutix™ To Present Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

BEDFORD, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the…

Ocular Therapeutix™ To Report First Quarter 2023 Financial Results

BEDFORD, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation,…

Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the…

Form 8-K OCULAR THERAPEUTIX, INC For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ocular Therapeutix stock rises after posting Q4 results beat, strong guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 4% and 3.50%, respectively, for the quarter ended December 2022. Do…

Form 8-K OCULAR THERAPEUTIX, INC For: Mar 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Shares of Ocular Therapeutix Jumped This Week

A promising report of a therapy in a phase 1 trial gave the stock a lift....…

Ocular Therapeutix (OCUL) Moves 35.1% Higher: Will This Strength Last?

Ocular Therapeutix (OCUL) saw its shares surge in the last session with trading volume being higher than average. The latest…

Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular Therapeutix: Why These 5 Stocks Are Drawing Heavy Attention Today

Major Wall Street indices closed over 1% higher on Monday ahead of the release of the consumer price index report…

Pre-market Movers: G1 Therapeutics, Vallon Pharmaceuticals, ZIVO Bioscience, Aceragen, Ocular Therapeutix

BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 07.35…

Ocular Therapeutix Shares Up 14% on OTX-TKI Retinal Treatment Data

Ocular Therapeutix Shares Up 14% on OTX-TKI Retinal Treatment Data...…

Insiderhandel: General Counsel verkauft Aktien von Ocular Therapeutix im Wert von 26.207$

Strassburger, Philip C. - Vorstand - Tag der Transaktion: 2023-02-06...…

Insiderhandel: Chief Business Officer verkauft Aktien von Ocular Therapeutix im Wert von 24.715$

White, Christopher G. - Vorstand - Tag der Transaktion: 2023-02-06...…

Insiderhandel: Chief Financial Officer verkauft Aktien von Ocular Therapeutix im Wert von 27.458$

Notman, Donald - Vorstand - Tag der Transaktion: 2023-02-06...…

Insiderhandel: Chief Medical Officer verkauft Aktien von Ocular Therapeutix im Wert von 27.204$

Ozden, Rabia Gurses - Vorstand - Tag der Transaktion: 2023-02-06...…

Insiderhandel: President and CEO verkauft Aktien von Ocular Therapeutix im Wert von 83.397$

Mattessich, Antony C. - Vorstand - Tag der Transaktion: 2023-02-06...…

Form 8-K OCULAR THERAPEUTIX, INC For: Jan 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

dpa-AFX ProFeed